SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 541 filers reported holding SEAGEN INC in Q2 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,397 | +10.3% | 16,010 | 0.0% | 0.06% | +1.6% |
| Q2 2023 | $3,081 | -5.0% | 16,010 | 0.0% | 0.06% | -10.1% |
| Q1 2023 | $3,242 | +57.6% | 16,010 | 0.0% | 0.07% | +50.0% |
| Q4 2022 | $2,057 | -99.9% | 16,010 | 0.0% | 0.05% | -14.8% |
| Q3 2022 | $2,191,000 | -22.7% | 16,010 | 0.0% | 0.05% | -18.2% |
| Q2 2022 | $2,833,000 | +111.6% | 16,010 | +72.3% | 0.07% | +65.0% |
| Q1 2022 | $1,339,000 | -6.8% | 9,294 | 0.0% | 0.04% | 0.0% |
| Q4 2021 | $1,437,000 | -69.0% | 9,294 | -65.9% | 0.04% | -76.6% |
| Q3 2021 | $4,634,000 | +310.1% | 27,289 | +281.1% | 0.17% | +271.7% |
| Q2 2021 | $1,130,000 | +13.7% | 7,160 | 0.0% | 0.05% | +4.5% |
| Q1 2021 | $994,000 | -20.7% | 7,160 | 0.0% | 0.04% | -25.4% |
| Q4 2020 | $1,254,000 | – | 7,160 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |